Synexus ( Site 1001) — Mesa, Arizona

Synexus ( Site 1001) is a clinical research site located in Mesa, Arizona, United States 85206.

Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.

Synexus ( Site 1001) has participated in 3 clinical trials.

Therapeutic areas: Pneumococcal Infections, Hypogonadism, Cardiovascular Diseases.

Sponsors: Merck Sharp & Dohme LLC, AbbVie.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Mesa

Browse all research sites in Arizona · View every site in Mesa

• Trillium Specialty Hospital
• Banner Baywood Heart Hospital
• A.T. Still University Arizona School of Health Sciences
• Banner Heart Hospital
• A.T. Still University, Arizona School of Dentistry & Oral Health
• Arizona State University, Nutrition Program
• Mountain Vista Hospital
• Desert Good Samaritan Hospital
• A.T. Still University
• Banner Children's at Desert
• GSK Investigational Site
• Research Site

Sponsor Feasibility Report

Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Synexus ( Site 1001)?

Synexus ( Site 1001) has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Synexus ( Site 1001) conducted?

Synexus ( Site 1001) has 3 clinical trials on record. Their work covers Pneumococcal Infections, Hypogonadism, Cardiovascular Diseases.

Is Synexus ( Site 1001) accredited by Crixeo Clinical Trials?

Synexus ( Site 1001) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Synexus ( Site 1001)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.